BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15212686)

  • 1. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data.
    Lenburg ME; Liou LS; Gerry NP; Frampton GM; Cohen HT; Christman MF
    BMC Cancer; 2003 Nov; 3():31. PubMed ID: 14641932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.
    Awakura Y; Nakamura E; Takahashi T; Kotani H; Mikami Y; Kadowaki T; Myoumoto A; Akiyama H; Ito N; Kamoto T; Manabe T; Nobumasa H; Tsujimoto G; Ogawa O
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1363-9. PubMed ID: 18483744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.
    Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Sano F; Baba M; Kondo K; Nakaigawa N; Kishida T; Nagashima Y; Yamada-Okabe H; Kubota Y
    Int J Cancer; 2008 Sep; 123(5):1126-32. PubMed ID: 18546273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles correlate with the morphology and metastasis characteristics of renal cell carcinoma cells.
    Ami Y; Shimazui T; Akaza H; Uematsu N; Yano Y; Tsujimoto G; Uchida K
    Oncol Rep; 2005 Jan; 13(1):75-80. PubMed ID: 15583805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein profiling in renal-cell carcinoma.
    Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
    Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma.
    Brito GC; Fachel AA; Vettore AL; Vignal GM; Gimba ER; Campos FS; Barcinski MA; Verjovski-Almeida S; Reis EM
    Mol Carcinog; 2008 Oct; 47(10):757-67. PubMed ID: 18348187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma.
    Diegmann J; Tomiuk S; Sanjmyatav J; Junker K; Hindermann W; von Eggeling F
    Int J Mol Med; 2006 Sep; 18(3):395-403. PubMed ID: 16865223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
    Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P
    Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of resveratrol on gene expression in renal cell carcinoma.
    Shi T; Liou LS; Sadhukhan P; Duan ZH; Novick AC; Hissong JG; Almasan A; DiDonato JA
    Cancer Biol Ther; 2004 Sep; 3(9):882-8. PubMed ID: 15280659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells.
    Dobashi S; Katagiri T; Hirota E; Ashida S; Daigo Y; Shuin T; Fujioka T; Miki T; Nakamura Y
    Oncol Rep; 2009 Feb; 21(2):305-12. PubMed ID: 19148500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of human renal carcinomas with functional taxonomic analysis.
    Gieseg MA; Cody T; Man MZ; Madore SJ; Rubin MA; Kaldjian EP
    BMC Bioinformatics; 2002 Sep; 3():26. PubMed ID: 12356337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.